38.04
price up icon2.05%   0.765
after-market Dopo l'orario di chiusura: 38.04
loading

Revolution Medicines Inc Azioni (RVMD) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
9.95%
264.71
240.76 216.31 175.71 156.64
Operating Income/Loss
9.95%
-264.71
-240.76 -216.31 -175.71 -156.64
Nonoperating Income/Loss
38.10%
16.93
27.34 20.99 19.42 23.41
Income/Loss From Continuing Operations Before Tax
16.11%
-247.79
-213.42 -195.32 -156.29 -133.23
Income/Loss From Continuing Operations After Tax
16.11%
-247.79
-213.42 -194.57 -156.29 -133.23
Net Income/Loss
16.11%
-247.79
-213.42 -194.57 -156.29 -133.23
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.23%
188.58
188.15 2.1613 166.84 165.14
Diluted Average Shares
0.23%
188.58
188.15 2.1613 166.84 165.14
Basic Earnings Per Share
15.93%
-1.31
-1.13 -1.13 -0.94 -0.81
Diluted Earnings Per Share
15.93%
-1.31
-1.13 -1.13 -0.94 -0.81
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Capitalizzazione:     |  Volume (24 ore):